相似文献
1
Prevalence of type 1 diabetes autoantibodies (GADA, IA2, and IAA) in overweight and obese children.
Diabetes Care. 2010 Apr;33(4):820-2. doi: 10.2337/dc09-1573. Epub 2009 Dec 29.
2
Autoimmune reaction against pancreatic beta cells in children and adolescents with simple obesity.
Front Endocrinol (Lausanne). 2022 Dec 14;13:1061671. doi: 10.3389/fendo.2022.1061671. eCollection 2022.
3
Islet autoantibody phenotypes and incidence in children at increased risk for type 1 diabetes.
Diabetologia. 2015 Oct;58(10):2317-23. doi: 10.1007/s00125-015-3672-y. Epub 2015 Jul 3.
4
[Autoantibodies to GAD65, IA2 and insulin in Czech children with type 1 diabetes].
Cas Lek Cesk. 2000 Sep 27;139(19):599-603.
5
Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes. The Childhood Diabetes In Finland Study Group.
J Clin Endocrinol Metab. 1999 May;84(5):1534-9. doi: 10.1210/jcem.84.5.5669.
6
Islet autoantibody positivity in overweight and obese adults with type 2 diabetes.
Autoimmunity. 2018 Dec;51(8):408-416. doi: 10.1080/08916934.2018.1547711. Epub 2019 Jan 2.
7
GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives.
Diabetes. 1998 Apr;47(4):592-7. doi: 10.2337/diabetes.47.4.592.
8
Prevalence of β-cell antibodies and associated autoimmune diseases in children and adolescents with type 1 diabetes (T1DM) versus type 2 diabetes (T2DM) in Qatar.
Acta Biomed. 2018 May 23;89(S5):32-39. doi: 10.23750/abm.v89iS4.7359.
9
Identification of autoimmune type 1 diabetes and multiple organ-specific autoantibodies in adult-onset non-insulin-requiring diabetes in China: A population-based multicentre nationwide survey.
Diabetes Obes Metab. 2019 Apr;21(4):893-902. doi: 10.1111/dom.13595. Epub 2018 Dec 25.
10
Disease-associated autoantibodies and HLA-DQB1 genotypes in children with newly diagnosed insulin-dependent diabetes mellitus (IDDM). The Childhood Diabetes in Finland Study Group.
Clin Exp Immunol. 1999 Apr;116(1):78-83. doi: 10.1046/j.1365-2249.1999.00863.x.
引用本文的文献
1
Research progress in the treatment of an immune system disease-type 1 diabetes-by regulating the intestinal flora with Chinese medicine and food homologous drugs.
Biosci Microbiota Food Health. 2024;43(3):150-161. doi: 10.12938/bmfh.2023-068. Epub 2024 Feb 21.
2
Autoimmune reaction against pancreatic beta cells in children and adolescents with simple obesity.
Front Endocrinol (Lausanne). 2022 Dec 14;13:1061671. doi: 10.3389/fendo.2022.1061671. eCollection 2022.
3
The Influence of Different Types of Diabetes on Vascular Complications.
J Diabetes Res. 2022 Feb 22;2022:3448618. doi: 10.1155/2022/3448618. eCollection 2022.
4
AIM associated with the IgM pentamer: attackers on stand-by at aircraft carrier.
Cell Mol Immunol. 2018 Jun;15(6):563-574. doi: 10.1038/cmi.2017.141. Epub 2018 Jan 29.
5
Presence of diabetes-specific autoimmunity in women with gestational diabetes mellitus (GDM) predicts impaired glucose regulation at follow-up.
J Endocrinol Invest. 2018 Sep;41(9):1061-1068. doi: 10.1007/s40618-018-0830-3. Epub 2018 Jan 16.
6
Successful management of insulin allergy and autoimmune polyendocrine syndrome type 4 with desensitization therapy and glucocorticoid treatment: a case report and review of the literature.
Case Reports Immunol. 2014;2014:394754. doi: 10.1155/2014/394754. Epub 2014 Nov 19.
7
Nardilysin-dependent proteolysis of cell-associated VTCN1 (B7-H4) marks type 1 diabetes development.
Diabetes. 2014 Oct;63(10):3470-82. doi: 10.2337/db14-0213. Epub 2014 May 21.
8
Stabilization and augmentation of circulating AIM in mice by synthesized IgM-Fc.
PLoS One. 2014 May 7;9(5):e97037. doi: 10.1371/journal.pone.0097037. eCollection 2014.
9
Impacts of the apoptosis inhibitor of macrophage (AIM) on obesity-associated inflammatory diseases.
Semin Immunopathol. 2014 Jan;36(1):3-12. doi: 10.1007/s00281-013-0405-5. Epub 2013 Nov 27.
10
Latent autoimmune diabetes of adults: From oral hypoglycemic agents to early insulin.
Indian J Endocrinol Metab. 2012 Mar;16 Suppl 1(Suppl1):S41-6. doi: 10.4103/2230-8210.94257.
本文引用的文献
1
The accelerator hypothesis: a review of the evidence for insulin resistance as the basis for type I as well as type II diabetes.
Int J Obes (Lond). 2009 Jul;33(7):716-26. doi: 10.1038/ijo.2009.97. Epub 2009 Jun 9.
2
Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study.
Lancet. 2009 Jun 13;373(9680):2027-33. doi: 10.1016/S0140-6736(09)60568-7. Epub 2009 May 27.
3
Diabetic subjects diagnosed through the Diabetes Prevention Trial-Type 1 (DPT-1) are often asymptomatic with normal A1C at diabetes onset.
Diabetes Care. 2009 May;32(5):769-73. doi: 10.2337/dc08-1872.
4
Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr).
J Endocrinol Invest. 2006 Jul-Aug;29(7):581-93. doi: 10.1007/BF03344156.
5
Testing the accelerator hypothesis: body size, beta-cell function, and age at onset of type 1 (autoimmune) diabetes.
Diabetes Care. 2006 Feb;29(2):290-4. doi: 10.2337/diacare.29.02.06.dc05-1339.
6
Type 1 diabetes among sardinian children is increasing: the Sardinian diabetes register for children aged 0-14 years (1989-1999).
Diabetes Care. 2004 Jul;27(7):1623-9. doi: 10.2337/diacare.27.7.1623.
7
The Karlsburg type 1 diabetes risk study of a normal schoolchild population: association of beta-cell autoantibodies and human leukocyte antigen-DQB1 alleles in antibody-positive individuals.
J Clin Endocrinol Metab. 2002 May;87(5):2254-61. doi: 10.1210/jcem.87.5.8491.
8
Risk of type 1 diabetes development in children with incidental hyperglycemia: A multicenter Italian study.
Diabetes Care. 2001 Jul;24(7):1210-6. doi: 10.2337/diacare.24.7.1210.
9
Obesity, increased linear growth, and risk of type 1 diabetes in children.
Diabetes Care. 2000 Dec;23(12):1755-60. doi: 10.2337/diacare.23.12.1755.
10
Zotero 插件